News | May 18, 2026
Glenmark Pharma introduces Vancomycin Injection in U.S. market
The product is bioequivalent and therapeutically equivalent to the reference listed drug by Fresenius Kabi USA, LLC.
The product is bioequivalent and therapeutically equivalent to the reference listed drug by Fresenius Kabi USA, LLC.
The certification follows an inspection conducted by the Malta Medicines Authority between January 29, 2026, and February 3, 2026
Darolutamide Tablets, 300 mg, had an estimated market size of US$ 3,155 million in the United States
Highlighting KEYTRUDA & expanding cancer pipeline
The global JAK inhibitors market is projected to REACH $56.78 billion by 2030, reflecting strong demand for targeted immunology treatments
Study published BY IIT Kanpur researchers could advance drug delivery and biomedical technologies
The CDMO segment saw a 22% decline in Q4 due to a strong base in the prior year
The clinical study in France evaluated the safety and feasibility of Robocath’s robotic-assisted coronary intervention platform across complex cardiac cases.
India’s institutions now need to upgrade TTOs as strategic innovation units rather than administrative support cells
Mumbai event on June 24–25 will spotlight real-world impact of pharmacovigilance beyond AI adoption
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
